VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) (“CEL SCI” or the “Company”) today announced that it has signed a funding agreement (the “Agreement”) with a company established by Lake Whillans, a firm specialized in the funding of litigation. Pursuant to the agreement, Lake Whillans Vehicle I, LLC will provide the Company with up to $5,000,000 in funding for litigation expenses to support its $50,000,000 arbitration claims against its former clinical research organization (“CRO”). The funding will be available to CEL-SCI if and when needed to fund the expenses of the ongoing arbitration and will only be repaid upon CEL-SCI receiving proceeds from the arbitration, subject to the terms and conditions of the Agreement.
Help employers find you! Check out all the jobs and post your resume.
